Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis

Sen Wang, Yuxin Chen, Xuejing Xu, Wei Hu, Han Shen _ and Junhao Chen

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:102437-102445. https://doi.org/10.18632/oncotarget.22261

Metrics: PDF 1475 views  |   HTML 2204 views  |   ?  


Sen Wang1,*, Yuxin Chen1,*, Xuejing Xu1, Wei Hu1, Han Shen1 and Junhao Chen1

1Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu Province, China

*These authors contributed equally to this work

Correspondence to:

Han Shen, email: [email protected]

Junhao Chen, email: [email protected]

Keywords: hepatitis B virus, hepatitis C virus, systemic lupus erythematosus, meta-analysis, systematic review

Received: August 08, 2017     Accepted: September 22, 2017     Published: November 01, 2017


We attempted to explore the prevalence of HBV and HCV infections in patients with systemic lupus erythematous (SLE) via a systematic review. Articles published before June 2017 and, related to prevalence rates for HBV and HCV infection in SLE patient were identified in PubMed, Embase, CNKI, and Wanfang databases. Based on these searches 22 studies were selected for further analysis. The OR of HBsAg positive rate in SLE patients compared with control population was 0.28, with significant heterogeneity identified among the studies (I2 = 92%, P < 0.00001). Following exclusion of one study, the adjusted OR of HBsAg in patients with SLE was 0.24, and no significant heterogeneity was observed (I2 = 32%, P = 0.15). The adjusted OR of HBcAb positive rate in SLE patients compared with control population was 0.40, with no significant heterogeneity between studies (I2 = 0%, P = 0.56). The risk of having HCV infection by SLE patients was higher compared with the control subjects (OR = 2.91). In conclusion, this meta-analysis suggested that SLE might exert a role of protection against HBV but not for HCV infection. Further epidemiological and experimental studies are necessary to explore the role and mechanisms by which SLE affects HBV/HCV infections.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22261